258 related articles for article (PubMed ID: 21873469)
1. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.
Francis H; DeMorrow S; Venter J; Onori P; White M; Gaudio E; Francis T; Greene JF; Tran S; Meininger CJ; Alpini G
Gut; 2012 May; 61(5):753-64. PubMed ID: 21873469
[TBL] [Abstract][Full Text] [Related]
2. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
[TBL] [Abstract][Full Text] [Related]
3. H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.
Francis H; Onori P; Gaudio E; Franchitto A; DeMorrow S; Venter J; Kopriva S; Carpino G; Mancinelli R; White M; Meng F; Vetuschi A; Sferra R; Alpini G
Mol Cancer Res; 2009 Oct; 7(10):1704-13. PubMed ID: 19825989
[TBL] [Abstract][Full Text] [Related]
4. Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling.
Graf A; Meng F; Hargrove L; Kennedy L; Han Y; Francis T; Hodges K; Ueno Y; Nguyen Q; Greene JF; Francis H
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G813-23. PubMed ID: 25169977
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the histamine/VEGF axis by miR-125b during cholestatic liver injury in mice.
Meng F; Onori P; Hargrove L; Han Y; Kennedy L; Graf A; Hodges K; Ueno Y; Francis T; Gaudio E; Francis HL
Am J Pathol; 2014 Mar; 184(3):662-73. PubMed ID: 24384130
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.
Frampton G; Invernizzi P; Bernuzzi F; Pae HY; Quinn M; Horvat D; Galindo C; Huang L; McMillin M; Cooper B; Rimassa L; DeMorrow S
Gut; 2012 Feb; 61(2):268-77. PubMed ID: 22068162
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.
Johnson C; Huynh V; Hargrove L; Kennedy L; Graf-Eaton A; Owens J; Trzeciakowski JP; Hodges K; DeMorrow S; Han Y; Wong L; Alpini G; Francis H
Am J Pathol; 2016 Jan; 186(1):123-33. PubMed ID: 26597881
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
9. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
[TBL] [Abstract][Full Text] [Related]
10. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer.
Cianchi F; Cortesini C; Schiavone N; Perna F; Magnelli L; Fanti E; Bani D; Messerini L; Fabbroni V; Perigli G; Capaccioli S; Masini E
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6807-15. PubMed ID: 16203768
[TBL] [Abstract][Full Text] [Related]
11. Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
Kennedy L; Meadows V; Demieville J; Hargrove L; Virani S; Glaser S; Zhou T; Rinehart E; Jaeger V; Kyritsi K; Pham L; Alpini G; Francis H
Lab Invest; 2020 Jun; 100(6):837-848. PubMed ID: 32054995
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
13. Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells.
Ku HJ; Kim HY; Kim HH; Park HJ; Cheong JH
World J Gastroenterol; 2014 Jan; 20(1):175-82. PubMed ID: 24415870
[TBL] [Abstract][Full Text] [Related]
14. Histamine restores biliary mass following carbon tetrachloride-induced damage in a cholestatic rat model.
Johnson C; Hargrove L; Graf A; Kennedy L; Hodges K; Harris R; Francis T; Ueno Y; Francis H
Dig Liver Dis; 2015 Mar; 47(3):211-7. PubMed ID: 25575430
[TBL] [Abstract][Full Text] [Related]
15. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
Frampton G; Coufal M; Li H; Ramirez J; DeMorrow S
Exp Cell Res; 2010 May; 316(9):1465-78. PubMed ID: 20347808
[TBL] [Abstract][Full Text] [Related]
16. Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.
Coufal M; Invernizzi P; Gaudio E; Bernuzzi F; Frampton GA; Onori P; Franchitto A; Carpino G; Ramirez JC; Alvaro D; Marzioni M; Battisti G; Benedetti A; DeMorrow S
Int J Cancer; 2010 May; 126(9):2112-22. PubMed ID: 19795457
[TBL] [Abstract][Full Text] [Related]
17. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
18. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.
Alpini G; Invernizzi P; Gaudio E; Venter J; Kopriva S; Bernuzzi F; Onori P; Franchitto A; Coufal M; Frampton G; Alvaro D; Lee SP; Marzioni M; Benedetti A; DeMorrow S
Cancer Res; 2008 Nov; 68(22):9184-93. PubMed ID: 19010890
[TBL] [Abstract][Full Text] [Related]
19. Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2
Kennedy L; Hargrove L; Demieville J; Karstens W; Jones H; DeMorrow S; Meng F; Invernizzi P; Bernuzzi F; Alpini G; Smith S; Akers A; Meadows V; Francis H
Hepatology; 2018 Sep; 68(3):1042-1056. PubMed ID: 29601088
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
Onori P; DeMorrow S; Gaudio E; Franchitto A; Mancinelli R; Venter J; Kopriva S; Ueno Y; Alvaro D; Savage J; Alpini G; Francis H
Int J Cancer; 2009 Aug; 125(3):565-76. PubMed ID: 19358267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
